[Use of totally implantable venous system in cancer patients. Surgical technique and initial clinical experience].
The experience with a totally implanted venous system (TIVS) in 27 cancer patients (15 males and 12 women) is reviewed, stressing simplicity of the cut down technique, which was successfully performed in 92.7% of patients. The common: est complications are described; port infection (7.4%), subclavian vein thrombosis (3.7%), and cutaneous necrosis (3.7%) at the port level. It is concluded that TIVS is a useful device for prolonged drugs administration and the cut down technique is indicated especially in the outpatients setting.
Ferranti
F
F
Azienda USL RM/F, Ospedale San Paolo, Civitavecchia, Roma.
Chichi
G L
GL
Mazzola
L
L
Triveri
P
P
Palmieri
R Macarone
RM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D005471:Fluoroscopy; D006801:Humans; D015918:Infusion Pumps, Implantable / Q000009:adverse effects; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D016748:Venous Cutdown
D000970:Antineoplastic Agents